A synthetic peptide for use as a blocking control in assays to test for specificity of THPO antibody, Alternative Names: Thrombopoietin control peptide, Thrombopoietin antibody Blocking Peptide, Anti-Thrombopoietin Blocking Peptide, MGC163194 Blocking Peptide, MGDF Blocking Peptide, MKCSF Blocking Peptide, ML Blocking Peptide, MPLLG Blocking Peptide, TPO Blocking Peptide, Myeloproliferative Leukemia Virus Oncogene Ligand Megakaryocyte Growth And Development Factor Blocking Peptide, THPO Blocking Peptide
THPO
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Thrombopoietin (THPO)
Hintergrund
Megakaryocytopoiesis is the cellular development process that leads to platelet production. THPO is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. THPO is the ligand for MLP/CMPL, the product of myeloproliferative leukemia virus oncogene.Megakaryocytopoiesis is the cellular development process that leads to platelet production.